MedPath
NMPA Approval

Tegileridine Fumarate Injection

国药准字H20240005

June 19, 2024

Drug Information

富马酸泰吉利定注射液

艾苏特

注射剂

1ml:1mg(按C₂₈H₃₈N₂O₂计)

化学药品

June 19, 2024

Company Information

Applicant Company

连云港经济技术开发区黄河路38号

Manufacturing Company

连云港经济技术开发区临港产业区东晋路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸泰吉利定注射液 - NMPA 批准文号 | MedPath